ADAC to highlight new cardiac camera
Nuclear medicine developer ADAC Laboratories of Milpitas, CA, will introduce a new version of its dedicated cardiac gamma camera at next month’s Society of Nuclear Medicine meeting in Los Angeles. ADAC has taken the basic design of its Cardio
Nuclear medicine developer ADAC Laboratories of Milpitas, CA, will introduce a new version of its dedicated cardiac gamma camera at next months Society of Nuclear Medicine meeting in Los Angeles. ADAC has taken the basic design of its Cardio system, a 90º fixed-angle dual-head system, and has upgraded it with the companys latest detectors. The new camera will be marketed as Cardio 60, according to Mohamed Elmandjra, vice president of marketing for ADAC.
Cardio 60 uses Epix HP digital detectors, which ADAC first introduced at last years RSNA conference, on the Vertex V60 variable-angle system (SCAN 12/16/98). The detectors improve count rates by 25% to 60% over the companys earlier version of Epix. Cardio 60 also features a powerful Ultra 60 workstation from Sun Microsystems.
In other new SNM introductions, ADAC will announce that it has begun shipments of Molecular Coincidence Detection and Molecular Coincidence Detection/Attenuation Correction on its premium Forte camera. ADAC will discuss clinical results with the high-energy techniques, as well as the improved reimbursement environment for PET studies (SCAN 3/17/99). The company will also give SNM attendees a status report on its CPET dedicated PET camera program, which Elmandjra said has been going well.
Other developments that will be highlighted include the companys radiation therapy program and its healthcare information technology business, which features image management software that can improve the work flow of nuclear medicine departments. ADAC will also discuss its recent alliance with Hitachi for nuclear medicine sales in Japan. Finally, ADAC has two other product announcements to make at the SNM meeting that the company declined to discuss in advance, Elmandjra said.
© 1999 Miller Freeman, Inc.All rights reserved.
Could AI-Powered Abbreviated MRI Reinvent Detection for Structural Abnormalities of the Knee?
April 24th 2025Employing deep learning image reconstruction, parallel imaging and multi-slice acceleration in a sub-five-minute 3T knee MRI, researchers noted 100 percent sensitivity and 99 percent specificity for anterior cruciate ligament (ACL) tears.
Meta-Analysis Shows Merits of AI with CTA Detection of Coronary Artery Stenosis and Calcified Plaque
April 16th 2025Artificial intelligence demonstrated higher AUC, sensitivity, and specificity than radiologists for detecting coronary artery stenosis > 50 percent on computed tomography angiography (CTA), according to a new 17-study meta-analysis.
Can CT-Based AI Radiomics Enhance Prediction of Recurrence-Free Survival for Non-Metastatic ccRCC?
April 14th 2025In comparison to a model based on clinicopathological risk factors, a CT radiomics-based machine learning model offered greater than a 10 percent higher AUC for predicting five-year recurrence-free survival in patients with non-metastatic clear cell renal cell carcinoma (ccRCC).
